National and Kapodistrian University of Athens
Αγγειακά εγκεφαλικά επεισόδια σε γυναίκες: ο ρόλος των ορμονών του φύλου
Abstract
dc:descriptionINTRODUCTION: Cerebrovascular disease is the third cause of death following cardiovascular disease and cancer, as well as a significant cause of severe disability. The neurological severity and outcome after acute stroke is worse in women compared to male patients. Studies focusing on hormonal replacement therapy could not show a protective effect of exogenous estrogens in primary and secondary stroke prevention. There is limited data on the role of endogenous sex hormones in the severity and prognosis of acute stroke in postmenopausal women. Additionally, the clinical significance of common genetic polymorphisms of the estrogen receptor genes, considered to affect tissue sensitivity to estrogenic action, has not been clarified. The aim of the present study was to search for associations between circulating sex hormone levels and the severity, outcome and other parameters of acute stroke. Furthermore, the clinical significance of the gene polymorphism of the estrogen receptor alpha (ERα) PvuII in the severity and prognosis of acute stroke was evaluated. PATIENTS- METHODS: We studied 302 postmenopausal women hospitalized for an acute stroke in two tertiary hospitals of Athens during a time period of two years. Medical and family history, as well as classical risk factors for stroke, were recorded. All patients underwent neurological examination and the severity of neurological impairment on admission was assessed using the National Institutes of Health Stroke Scale (NIHSS). One month after the acute stroke, the degree of disability and handicap was assessed using the modified Rankin Scale (mRS). On the 2nd-3rd day after the episode, blood sampling for biochemical investigation and hormonal evaluation (17β-estradiol with a high sensitivity method, progesterone, DHEAS, Δ4-androstenedione, testosterone, SHBG, insulin and prolactin) was performed. ERα polymorphism at position c.454-397 T>C (PvuII) was genotyped. RESULTS: The mean age of the patients was 73.6±12.9 years and their body mass index 28.7±5.7 kg/m2. The prevalence of arterial hypertension was 77.7% and diabetes 25.1%, whereas 26.2% of the patients had previous history of cerebrovascular disease. The majority of stroke events were ischemic and intracerebral hemorrhage was evident in 41 patients. The mean NIHSS score, an index of neurological severity on admission, was 10.7±7.4. One month after the episode, 161 patients had an adverse outcome, in detail 136 patients had severe disability (mRS≥4) and 25 had died. The initial statistical analysis included only the androgen levels and it was shown that Δ4-androstenedione and DHEAS levels, systolic blood pressure, HDL concentration and the presence of atrial fibrillation and intracerebral hemorrhage were independent determinants of the neurological severity on admission, as expressed by the natural logarithm of the NIHSS (logNIHSS). After including estradiol levels in the analysis, it was found that estradiol was an independent determinant of logNIHSS, and the association of Δ4-androstenedione and DHEAS was attenuated. Regarding one-month disability, the independent factors in the initial multivariate model were patients’ age, NIHSS and intracerebral hemorrhage. After including estradiol in the analysis, the independent determinants of severe disability one month after stroke were estradiol, NIHSS and intracerebral hemorrhage. Concerning one-month mortality, the independent factors in the first analysis were Δ4-androstenedione and NIHSS and in the second analysis the independent factors were estradiol levels, NIHSS and the presence of arterial hypertension. The distribution of the ERα PvuII polymorphism was: CC 21% (N=59), TC 50% (N=142) and TT 29% (N=84). There was no significant difference in the neurological severity on admission nor the one-month handicap and mortality between the three genotype groups. The prevalence of intracerebral hemorrhage and of the classical stroke risk factors was similar in the three groups. We found a significant difference in the prevalence of venous thromboembolism (VTE) between the genotype groups; the prevalence of VTE was 5% in CC patients, 2.8% in CT and 0% in TT patients (p 0.05). Furthermore, we showed a significant positive relation of the C allele with increasing estradiol levels. CONCLUSIONS: In the studied population of postmenopausal acute stroke women, higher estradiol levels were independently associated with the neurological severity on admission and the one-month mortality and handicap. It is possible that circulating estradiol reflects the sum of endogenous androgens that are peripherally aromatized. Another hypothesis is that the acute stroke itself alters estradiol levels and, thus, the latter represent a surrogate of the underlying disease or, alternatively, a homeostatic mechanism counteracting the pathophysiologic process. In addition, it was shown that the ERα PvuII gene polymorphism was not related to the severity and the prognosis of acute stroke in this population of postmenopausal women. One cannot exclude the possibility that the long-term exposure and sensitivity to estrogen, reflected by the genetic polymorphism, may become less important many years after menopause, as in the case of the studied postmenopausal acute stroke women.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2012
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Pappa, Theodora
- Παππά, Θεοδώρα
Subjects
dc:subject × 18- Αγγειακά εγκεφαλικά επεισόδια
- Εμμηνόπαυση
- Οιστρογόνα
- Ανδρογόνα
- Οιστρογονικός υποδοχέας άλφα
- Γενετικός πολυμορφισμός
- Αγγειακή εγκεφαλική νόσος
- Stroke
- Menopause
- Estrogens
- Androgens
- Estrogen receptor alpha
- Genetic polymorphisms
- Cerebrovascular diseases
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Medical and Health Sciences
- Basic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/29839